Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics

Journal of Physiology

Volumn 590, Issue 5, 2012, Pages 1035-1044

  Hering, Nina A ^a   Fromm, Michael ^b   Schulzke, Jörg Dieter ^a  

^a Division of Nutritional Medicine   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; ZINC;

CROHN DISEASE; DIET SUPPLEMENTATION; ENTERITIS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HUMAN; INTESTINE FUNCTION; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TIGHT JUNCTION; ULCERATIVE COLITIS;

ANIMALS; COLON; CYTOKINES; HUMANS; INFLAMMATORY BOWEL DISEASES; TIGHT JUNCTIONS;

EID: 84857682579     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.224568     Document Type: Review

References (84)

1. Afif W, Leighton JA, Hanauer SB, Loftus EV Jr, Faubion WA, Pardi DS, Tremaine WJ, Kane SV, Bruining DH, Cohen RD, Rubin DT, Hanson KA & Sandborn WJ (2009). Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab. Inflamm Bowel Dis 15, 1302-1307.
2. Ahn SH, Shah YM, Inoue J, Morimura K, Kim I, Yim S, Lambert G, Kurotani R, Nagashima K, Gonzalez FJ & Inoue Y (2008). Hepatocyte nuclear factor 4α in the intestinal epithelial cells protects against inflammatory bowel disease. Inflamm Bowel Dis 14, 908-920.
3. Al-Sadi R, Ye D, Said HM & Ma TY (2011). Cellular and molecular mechanism of interleukin-1β modulation of Caco2 intestinal epithelial tight junction barrier. J Cell Mol Med 15, 970-982.
4. Amasheh M, Fromm A, Krug SM, Amasheh S, Andres S, Zeitz M, Fromm M & Schulzke JD (2010). TNFα-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFκB signaling. J Cell Sci 123, 4145-4155.
5. Amasheh M, Grotjohann I, Amasheh S, Fromm A, Soderholm JD, Zeitz M, Fromm M & Schulzke JD (2009a). Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol 44, 1226-1235.
6. Amasheh M, Schlichter S, Amasheh S, Mankertz J, Zeitz M, Fromm M & Schulzke JD (2008). Quercetin enhances epithelial barrier function and increases claudin 4 expression in Caco 2 cells. J Nutr 138, 1067-1073.
7. Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD & Fromm M (2002). Claudin 2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 115, 4969-4976.
8. + absorption defends from paracellular back-leakage by claudin 8 upregulation. Biochem Biophys Res Commun 378, 45-50.
9. Amasheh S, Schmidt T, Mahn M, Florian P, Mankertz J, Tavalali S, Gitter AH, Schulzke JD & Fromm M (2005). Contribution of claudin 5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res 321, 89-96.
10. Barrett JC, Lee JC, Lees CW, Prescott NJ, Anderson CA, Phillips A, Wesley E, Parnell K, Zhang H, Drummond H, et al (2009). Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet 41, 1330-1334.
11. Battle MA, Konopka G, Parviz F, Gaggl AL, Yang C, Sladek FM & Duncan SA (2006). Hepatocyte nuclear factor 4α orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver. Proc Natl Acad Sci U S A 103, 8419-8424.
12. Blair SA, Kane SV, Clayburgh DR & Turner JR (2006). Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest 86, 191-201.
13. Bojarski C, Gitter AH, Bendfeldt K, Mankertz J, Schmitz H, Wagner S, Fromm M & Schulzke JD (2001). Permeability of human HT-29/B6 colonic epithelium as a function of apoptosis. J Physiol 535, 541-552.
14. Bruewer M, Utech M, Ivanov AI, Hopkins AM, Parkos CA & Nusrat A (2005). Interferon-γ induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J 19, 923-933.
15. Bucker R, Troeger H, Kleer J, Fromm M & Schulzke JD (2009). Arcobacter butzleri induces barrier dysfunction in intestinal HT-29/B6 Cells. J Infect Dis 200, 756-764.
16. Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A, Kuechler I, Krueger S, Schmidt HH & Lochs H (2006). Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut 55, 342-347.
17. Burgel N, Bojarski C, Mankertz J, Zeitz M, Fromm M & Schulzke JD (2002). Mechanisms of diarrhea in collagenous colitis. Gastroenterology 123, 433-443.
18. Chapman MA, Grahn MF, Boyle MA, Hutton M, Rogers J & Williams NS (1994). Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut 35, 73-76.
19. Clark E, Hoare C, Tanianis-Hughes J, Carlson GL & Warhurst G (2005). Interferon γ induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 128, 1258-1267.
20. Clark EC, Patel SD, Chadwick PR, Warhurst G, Curry A & Carlson GL (2003). Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate. Gut 52, 224-230.
21. Darsigny M, Babeu JP, Dupuis AA, Furth EE, Seidman EG, Lévy E, Verdu EF, Gendron FP & Boudreau F (2009). Loss of hepatocyte-nuclear-factor-4α affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PLoS One 4, e7609.
22. Dieleman LA, Hoentjen F, Qian BF, Sprengers D, Tjwa E, Torres MF, Torrice CD, Sartor RB & Tonkonogy SL (2004). Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin Exp Immunol 136, 30-39.
23. D'Incà R, Annese V, Leo Di V, Latiano A, Quaino V, Abazia C, Vettorato MG & Sturniolo GC (2006). Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. Aliment Pharmacol Ther 23, 1455-1461.
24. Eeckhoute J, Formstecher P & Laine B (2004). Hepatocyte nuclear factor 4α enhances the hepatocyte nuclear factor 1α-mediated activation of transcription. Nucleic Acids Res 32, 2586-2593.
25. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG & Weaver CT (2005). Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206, 260-276.
26. Escaffit F, Boudreau F & Beaulieu JF (2005). Differential expression of claudin 2 along the human intestine: Implication of GATA 4 in the maintenance of claudin 2 in differentiating cells. J Cell Physiol 203, 15-26.
27. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, Noda T, Kubo A & Tsukita S (2002). Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 156, 1099-1111.
28. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S & Tsukita S (1993). Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123, 1777-1788.
29. Gitter AH, Bendfeldt K, Schulzke JD & Fromm M (2000). Leaks in the epithelial barrier caused by spontaneous and TNF-αinduced single-cell apoptosis. FASEB J 14, 1749-1753.
30. Gunzel D, Stuiver M, Kausalya PJ, Haisch L, Krug SM, Rosenthal R, Meij IC, Hunziker W, Fromm M & Muller D (2009). Claudin-10 exists in six alternatively spliced isoforms that exhibit distinct localization and function. J Cell Sci 122, 1507-1517.
31. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Burgel N, Fromm M, Zeitz M, Fuss I, Strober W & Schulzke JD (2005). Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129, 550-564.
32. Hering NA, Andres S, Fromm A, Tol Van EA, Amasheh M, Mankertz J, Fromm M & Schulzke JD (2011a). Transforming growth factor-β, a whey protein component, strengthens the intestinal barrier by upregulating claudin 4 in HT-29/B6 cells. J Nutr 141, 783-789.
33. Hering NA, Richter JF, Krug SM, Gunzel D, Fromm A, Bohn E, Rosenthal R, Bucker R, Fromm M, Troeger H & Schulzke JD (2011b). Yersinia enterocolitica induces epithelial barrier dysfunction through regional tight junction changes in colonic HT-29/B6 cell monolayers. Lab Invest 91, 310-324.
34. Hering NA, Richter JF, Krug SM, Günzel D, Fromm A, Bohn E, Rosenthal R, Bücker R, Fromm M, Troeger H & Schulzke JD (2011c). Modulation of epithelial barrier function by pathogenic Y. enterocolitica or probiotic E. coli Nissle. FASEB J 25, 1036.6
35. Hudcovic T, Stepankova R, Cebra J & Tlaskalova-Hogenova H (2001). The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice. Folia Microbiol (Praha) 46, 565-572.
36. Ikenouchi J, Furuse M, Furuse K, Sasaki H & Tsukita S (2005). Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 171, 939-945.
37. John LJ, Fromm M & Schulzke JD (2011). Epithelial barriers in intestinal inflammation. Antioxid Redox Signal 15, 1255-1270.
38. Krishnan S, Ramakrishna BS & Binder HJ (1999). Stimulation of sodium chloride absorption from secreting rat colon by short-chain fatty acids. Dig Dis Sci 44, 1924-1930.
39. Krug SM, Amasheh S, Richter JF, Milatz S, Gunzel D, Westphal JK, Huber O, Schulzke JD & Fromm M (2009). Tricellulin forms a barrier to macromolecules in tricellular tight junctions without affecting ion permeability. Mol Biol Cell 20, 3713-3724.
40. Krug SM, Bojarski C, Fromm A, Schulzke JD & Fromm M (2010) Tricellulin in Crohn's disease and ulcerative colitis. FASEB J 24, 998.1
41. Lala S, Ogura Y, Osborne C, Hor SY, Bromfield A, Davies S, Ogunbiyi O, Nunez G & Keshav S (2003). Crohn's disease and the NOD2 gene: a role for paneth cells. Gastroenterology 125, 47-57.
42. Lewis K, Lutgendorff F, Phan V, Söderholm JD, Sherman PM & McKay DM (2010). Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis 16, 1138-1148.
43. Mankertz J, Amasheh M, Krug SM, Fromm A, Amasheh S, Hillenbrand B, Tavalali S, Fromm M & Schulzke JD (2009). TNFα up-regulates claudin 2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling. Cell Tissue Res 336, 67-77.
44. Marchiando AM, Shen L, Graham WV, Edelblum KL, Duckworth CA, Guan Y, Montrose MH, Turner JR & Watson AJ (2011). The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology 140, 1208-1218.
45. Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR 2nd, Raleigh DR, Guan Y, Watson AJ, Montrose MH & Turner JR (2010). Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol 189, 111-126.
46. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A, Simmons D & Dejana E (1998). Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 142, 117-127.
47. Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N & Bruewer M (2009). Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 296, G1140-G1149.
48. Milatz S, Krug SM, Rosenthal R, Gunzel D, Muller D, Schulzke JD, Amasheh S & Fromm M (2010). Claudin 3 acts as a sealing component of the tight junction for ions of either charge and uncharged solutes. Biochim Biophys Acta 1798, 2048-2057.
49. Monteleone G, Boirivant M, Pallone F & Macdonald TT (2008). TGF-β1 and Smad7 in the regulation of IBD. Mucosal Immunol 1 (Suppl. 1), S50-S53.
50. Nielsen HL, Nielsen H, Ejlertsen T, Engberg J, Gunzel D, Zeitz M, Hering NA, Fromm M, Schulzke JD & Bucker R (2011). Oral and fecal Campylobacter concisus strains perturb barrier function by apoptosis induction in HT-29/B6 intestinal epithelial cells. PLoS One 6, e23858.
51. Plöger S, Bergann T, Fromm A, Bücker R, Fromm M & Schulzke JD (2010) Effect of sodium butyrate on barrier function of HT-29/B6-Tet-On-GR-MR cells in conjunction with down-regulation of claudin 2. Genes Nutr 5 (Suppl. 1), S28.
52. Prasad AS, Bao B, Beck FW, Kucuk O & Sarkar FH (2004). Antioxidant effect of zinc in humans. Free Radic Biol Med 37, 1182-1190.
53. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM & Axon AT (1999). Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354, 635-639.
54. Roselli M, Finamore A, Britti MS & Mengheri E (2006). Probiotic bacteria Bifidobacterium animalis MB5 and Lactobacillus rhamnosus GG protect intestinal Caco 2 cells from the inflammation-associated response induced by enterotoxigenic Escherichia coli K88. Br J Nutr 95, 1177-1184.
55. Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D & Schreiber S (2003). TNF-α and IFN-γ regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124, 1001-1009.
56. Rosenthal R, Milatz S, Krug SM, Oelrich B, Schulzke JD, Amasheh S, Gunzel D & Fromm M (2010). Claudin 2, a component of the tight junction, forms a paracellular water channel. J Cell Sci 123, 1913-1921.
57. Sakaguchi T, Gu X, Golden HM, Suh E, Rhoads DB & Reinecker HC (2002). Cloning of the human claudin-2 5′-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1α. J Biol Chem 277, 21361-21370.
58. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ, Riecken EO & Schulzke JD (1999a). Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116, 301-309.
59. Schmitz H, Fromm M, Bentzel CJ, Scholz P, Detjen K, Mankertz J, Bode H, Epple HJ, Riecken EO & Schulzke JD (1999b). Tumor necrosis factor-alpha (TNFα) regulates the epithelial barrier in the human intestinal cell line HT-29/B6. J Cell Sci 112, 137-146.
60. Schumann M, Gunzel D, Buergel N, Richter JF, Troeger H, May C, Fromm A, Sorgenfrei D, Daum S, Bojarski C, Heyman M, Zeitz M, Fromm M & Schulzke JD (2012). Cell polarity-determining proteins Par 3 and PP 1 are involved in epithelial tight junction defects in coeliac disease. Gut 61, 220-228.
61. Segain JP, Blétière Raingeard De La D, Bourreille A, Leray V, Gervois N, Rosales C, Ferrier L, Bonnet C, Blottière HM & Galmiche JP (2000). Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease. Gut 47, 397-403.
62. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM & Sartor RB (1998). Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66, 5224-5231.
63. Sepehri S, Kotlowski R, Bernstein CN & Krause DO (2007). Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis 13, 675-683.
64. Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE & Turner JR (2006). Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J Cell Sci 119, 2095-2106.
65. Staehelin LA (1973). Further observations on the fine structure of freeze-cleaved tight junctions. J Cell Sci 13, 763-786.
66. Sturniolo GC, Leo Di V, Ferronato A, D'Odorico A & D'Inca R (2001). Zinc supplementation tightens "leaky gut" in Crohn's disease. Inflamm Bowel Dis 7, 94-98.
67. Tagkalidis PP, Gibson PR & Bhathal PS (2007). Microscopic colitis demonstrates a T helper cell type 1 mucosal cytokine profile. J Clin Pathol 60, 382-387.
68. + deficiency and glucose malabsorption in mouse small intestine. Gastroenterology 140, 913-923.
69. Tedelind S, Westberg F, Kjerrulf M & Vidal A (2007). Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 13, 2826-2832.
70. Troeger H, Richter JF, Beutin L, Gunzel D, Dobrindt U, Epple HJ, Gitter AH, Zeitz M, Fromm M & Schulzke JD (2007). Escherichia coliα-haemolysin induces focal leaks in colonic epithelium: a novel mechanism of bacterial translocation. Cell Microbiol 9, 2530-2540.
71. Tsukita S, Furuse M & Itoh M (2001). Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2, 285-293.
72. Ukena SN, Singh A, Dringenberg U, Engelhardt R, Seidler U, Hansen W, Bleich A, Bruder D, Franzke A, Rogler G, Suerbaum S, Buer J, Gunzer F & Westendorf AM (2007). Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS One 12, e1308.
73. Itallie Van C, Rahner C & Anderson JM (2001). Regulated expression of claudin 4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 107, 1319-1327.
74. Itallie Van CM & Anderson JM (2006). Claudins and epithelial paracellular transport. Annu Rev Physiol 68, 403-429.
75. Voss E, Wehkamp J, Wehkamp K, Stange EF, Schroder JM & Harder J (2006). NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 281, 2005-2011.
76. Wapenaar MC, Monsuur AJ, Bodegraven van AA, Weersma RK, Bevova MR, Linskens RK, Howdle P, Holmes G, Mulder CJ, Dijkstra G, Heel van DA & Wijmenga C (2008). Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 57, 463-467.
77. Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y & Turner JR (2010). Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem 285, 12037-12046.
78. Wehkamp J, Harder J, Weichenthal M, Schwab M, Schaffeler E, Schlee M, Herrlinger KR, Stallmach A, Noack F, Fritz P, Schroder JM, Bevins CL, Fellermann K & Stange EF (2004). NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α defensin expression. Gut 53, 1658-1664.
79. Ye D & Ma TY (2008). Cellular and molecular mechanisms that mediate basal and tumour necrosis factor-α-induced regulation of myosin light chain kinase gene activity. J Cell Mol Med 12, 1331-1346.
80. Yu D, Marchiando AM, Weber CR, Raleigh DR, Wang Y, Shen L & Turner JR (2010). MLCK-dependent exchange and actin binding region-dependent anchoring of ZO 1 regulate tight junction barrier function. Proc Natl Acad Sci U S A 107, 8237-8241.
81. Zeissig S, Bojarski C, Buergel N, Mankertz J, Zeitz M, Fromm M & Schulzke JD (2004). Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor α antibody treatment. Gut 53, 1295-1302.
82. Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M & Schulzke JD (2007). Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56, 61-72.
83. Zhang B & Guo Y (2009). Supplemental zinc reduced intestinal permeability by enhancing occludin and zonula occludens protein 1 (ZO 1) expression in weaning piglets. Br J Nutr 102, 687-693.
84. Zhou H & Mineshita S (2000). The effect of berberine chloride on experimental colitis in rats in vivo and in vitro. J Pharmacol Exp Ther 294, 822-829.